PMID: 6413566Oct 1, 1983Paper

Inhibition of rat mast cell arachidonic acid cyclooxygenase by dapsone

The Journal of Allergy and Clinical Immunology
T RuzickaM P Printz

Abstract

Dapsone (diaminodiphenylsulfone) has been used therapeutically for a variety of disorders in which mast cell participation has been demonstrated, including bullous pemphigoid and some form of necrotizing vasculitis. The mechanism of action of dapsone in these disorders is unknown but potentially relates to inhibition of mast cell activation and prevention of generation and/or release of mast cell mediators. Evidence for this possibility has been obtained in rat mast cells in which dapsone in a concentration-dependent manner prevented generation of prostaglandin D2 PGD2 from exogenous or endogenous arachidonic acid with 50% inhibition achieved at 1 and 0.2 to 0.4 mM, respectively. Dapsone inhibited cyclooxygenase conversion of arachidonic acid to PGD2 but not the GSH-dependent conversion of 14C-PGH2 to PGD2 by PGH-D isomerase in broken cell preparations. Dapsone prevented the immunologic generation of PGD2 from antigen-challenged rat mast cells but did not affect the release of histamine. Thus dapsone may exert some of its therapeutic effects by prevention of mast cell PGD2 generation.

Citations

Nov 1, 1990·Journal of Dermatological Science·T Ruzicka
Mar 1, 1985·Journal of the American Academy of Dermatology·D K FalkL E King
Nov 1, 1991·Postgraduate Medical Journal·B I Hoffbrand
Jun 1, 1994·Postgraduate Medical Journal·P S Sarma
Oct 15, 2009·American Journal of Clinical Dermatology·Hakan M Gürcan, A Razzaque Ahmed
Dec 7, 2013·Archives of Dermatological Research·Gottfried Wozel, Christian Blasum
Jul 7, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·T K HoffmannP Lehmann
Jun 1, 2010·Dermatologic Clinics·V E Gottfried Wozel
Jan 1, 1988·Journal of the American Academy of Dermatology·P BernardJ M Bonnetblanc
Jul 1, 1989·Clinics in Dermatology·J Uetrecht
Apr 1, 1988·International Journal of Dermatology·K Ikai, S Imamura
Jan 13, 2001·Dermatologic Clinics·U Paniker, N Levine
Aug 15, 1989·Biochemical Pharmacology·K IkaiY Urade
Aug 21, 2001·Journal of the American Academy of Dermatology·Y I Zhu, M J Stiller
Jan 1, 1989·The British Journal of Dermatology·S WrightI M Leigh
Oct 1, 1988·International Journal of Dermatology·G Wozel, J Barth
Jun 1, 1994·Postgraduate Medical Journal·A A Deodhar, A D Woolf
Apr 5, 2019·American Journal of Therapeutics·Giulia MerloAurora Parodi
Apr 6, 2021·Archives of Medical Research·Razieh Mohammad JafariAhmad Reza Dehpour
Apr 1, 1987·Journal of the American Academy of Dermatology·M F Fredenberg, F D Malkinson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.